| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Annals of Thoracic Surgery, Vol 43, 155-159, Copyright © 1987 by The Society of Thoracic Surgeons
GA Patterson, D Piazza, FG Pearson, TR Todd, RJ Ginsberg, M Goldberg, P Waters, D Jones, R Ilves and JD Cooper
Thirty-five patients underwent resection of primary bronchogenic carcinoma
of the left upper lobe or left main bronchus in the presence of metastatic
disease in subaortic lymph nodes. No patient had metastatic disease in
other mediastinal node stations. There was 1 postoperative death. Complete
follow-up is available on 34 patients. Three-year and five-year actuarial
survival for the entire group is 44% and 28%, respectively. For 23 patients
undergoing complete resection, five-year actuarial survival is 42%.
Resection of primary bronchogenic carcinoma in the presence of subaortic
nodal metastases is associated with improved survival relative to reports
of survival following resection of metastatic disease in other mediastinal
node stations. Resection should be undertaken in these patients especially
when it is judged that the resection is likely to be complete.
ARTICLES
Significance of metastatic disease in subaortic lymph nodes
This article has been cited by other articles:
|
|
 |
|
  M. Riquet, P. Bagan, F. Le Pimpec Barthes, E. Banu, F. Scotte, C. Foucault, A. Dujon, and C. Danel Completely Resected Non-Small Cell Lung Cancer: Reconsidering Prognostic Value and Significance of N2 Metastases Ann. Thorac. Surg., December 1, 2007; 84(6): 1818 - 1824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Cerfolio, A. S. Bryant, and M. A. Eloubeidi Accessing the Aortopulmonary Window (#5) and the Paraaortic (#6) Lymph Nodes in Patients With Non-Small Cell Lung Cancer Ann. Thorac. Surg., September 1, 2007; 84(3): 940 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. C. Detterbeck, M. A. Jantz, M. Wallace, J. Vansteenkiste, and G. A. Silvestri Invasive Mediastinal Staging of Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 202S - 220S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Nechala, A. J. Graham, S. D. McFadden, S. C. Grondin, and G. Gelfand Retrospective Analysis of the Clinical Performance of Anterior Mediastinotomy Ann. Thorac. Surg., December 1, 2006; 82(6): 2004 - 2009. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. W. Martin, A. M. Correa, W. Hofstetter, W. K. Hong, R. Komaki, J. B. Putnam Jr, D. C. Rice, W. R. Smythe, S. G. Swisher, A. A. Vaporciyan, et al. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution J. Thorac. Cardiovasc. Surg., December 1, 2005; 130(6): 1601 - 1610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Casali, A. Stefani, P. Natali, G. Rossi, and U. Morandi Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 33 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Patel and J. B. Shrager Which Patients with Stage III Non-Small Cell Lung Cancer Should Undergo Surgical Resection? Oncologist, May 1, 2005; 10(5): 335 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. B. Ratto, R. Costa, G. Vassallo, A. Alloisio, P. Maineri, and P. Bruzzi Twelve-year experience with left atrial resection in the treatment of non-small cell lung cancer Ann. Thorac. Surg., July 1, 2004; 78(1): 234 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Keller, M. G. Vangel, H. Wagner, J. H. Schiller, A. Herskovic, R. Komaki, R. S. Marks, M. C. Perry, R. B. Livingston, and D. H. Johnson Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 130 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Inoue, N. Sawabata, S.-i. Takeda, M. Ohta, Y. Ohno, and H. Maeda Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: Acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1100 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. C. Detterbeck, M. M. DeCamp Jr., L. J. Kohman, and G. A. Silvestri Invasive Staging: The Guidelines Chest, January 1, 2003; 123(1_suppl): 167S - 175S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. E. Schmidt, E. A. Woltering, W. R. Webb, O. M. Garcia, J. E. Cohen, and M. H. Rozans Sentinel nodal assessment in patients with carcinoma of the lung Ann. Thorac. Surg., September 1, 2002; 74(3): 870 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Deslauriers Current surgical treatment of nonsmall cell lung cancer 2001 Eur. Respir. J., February 1, 2002; 19(35_suppl): 61S - 70s. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Komaki, M. H. Chasen, W. D. Travis, J. B. Putnam, F. V. Fossella, R. W. Byhardt, and J. Y. Ro Oncodiagnosis Panel: 1999: Cancer of the Lung: Oncodiagnosis RadioGraphics, November 1, 2001; 21(6): 1573 - 1596. [Full Text] [PDF]
|
|
|
|
 |
|
 British Thoracic Society, Society of Cardiothoracic Surgeons of Great Britai, and Ireland Working Party Guidelines on the selection of patients with lung cancer for surgery Thorax, February 1, 2001; 56(2): 89 - 108. [Full Text]
|
|
|
|
|
|
M. J. Liptay, G. A. Masters, D. J. Winchester, B. L. Edelman, B. J. Garrido, T. R. Hirschtritt, R. M. Perlman, and W. A. Fry Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer Ann. Thorac. Surg., August 1, 2000; 70(2): 384 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka Induction Therapy for Non-small Cell Lung Cancer With Involved Mediastinal Nodes in Multiple Stations Chest, July 1, 2000; 118(1): 123 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Deslauriers and J. Gregoire Clinical and Surgical Staging of Non-Small Cell Lung Cancer Chest, April 1, 2000; 117(4_suppl_1): 96S - 103S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Hammoud, R. C. Anderson, B. F. Meyers, T. J. Guthrie, C. L. Roper, J. D. Cooper, and G. A. Patterson THE CURRENT ROLE OF MEDIASTINOSCOPY IN THE EVALUATION OF THORACIC DISEASE J. Thorac. Cardiovasc. Surg., November 1, 1999; 118(5): 894 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka PROGNOSIS OF COMPLETELY RESECTED pN2 NON-SMALL CELL LUNG CARCINOMAS: WHAT IS THE SIGNIFICANT NODE THAT AFFECTS SURVIVAL? J. Thorac. Cardiovasc. Surg., August 1, 1999; 118(2): 270 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Krasna, C. E. Reed, W. C. Nugent, J. Olak, D. J. Sugarbaker, M. R. Green, and L. J. Kohman Lung cancer staging and treatment in multidisciplinary trials: cancer and leukemia group B cooperative group approach Ann. Thorac. Surg., July 1, 1999; 68(1): 201 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okada, N. Tsubota, M. Yoshimura, and Y. Miyamoto PROPOSAL FOR REASONABLE MEDIASTINAL LYMPHADENECTOMY IN BRONCHOGENIC CARCINOMAS: ROLE OF SUBCARINAL NODES IN SELECTIVE DISSECTION J. Thorac. Cardiovasc. Surg., December 1, 1998; 116(6): 949 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Scott, J. Shepherd, and S. S. Gambhir Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis Ann. Thorac. Surg., December 1, 1998; 66(6): 1876 - 1883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Vansteenkiste, P. De Leyn, G. Deneffe, J. Menten, T. Lerut, and M. Demedts Present status of induction treatment in stage IIIA-N2 non-small cell lung cancer: a review Eur. J. Cardiothorac. Surg., January 1, 1998; 13(1): 1 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Lacasse, H. C. Bucher, E. Wong, L. Griffith, S. Walter, R. J. Ginsberg, and G. H. Guyatt MD, "Incomplete Resection" in Non-Small Cell Lung Cancer: Need for a New Definition Ann. Thorac. Surg., January 1, 1998; 65(1): 220 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Sawyer, J. A. Bonner, P. M. Gould, R. L. Foote, C. Deschamps, V. F. Trastek, P. C. Pairolero, M. S. Allen, C. M. Lange, and H. Li Effectiveness of Postoperative Irradiation in Stage IIIA Non-Small Cell Lung Cancer According to Regression Tree Analyses of Recurrence Risks Ann. Thorac. Surg., November 1, 1997; 64(5): 1402 - 1407. [Abstract] [Full Text]
|
|
|
|
|
|
R. Nakanishi, T. Osaki, K. Nakanishi, I. Yoshino, T. Yoshimatsu, H. Watanabe, H. Nakata, and K. Yasumoto Treatment Strategy for Patients With Surgically Discovered N2 Stage IIIA Non-Small Cell Lung Cancer Ann. Thorac. Surg., August 1, 1997; 64(2): 342 - 348. [Abstract] [Full Text]
|
|
|
|
|
|
J. F. Vansteenkiste, P. R. De Leyn, G. J. Deneffe, G. Stalpaert, K. L. Nackaerts, T. E. Lerut, and M. G. Demedts Survival and Prognostic Factors in Resected N2 Non-Small Cell Lung Cancer: A Study of 140 Cases Ann. Thorac. Surg., May 1, 1997; 63(5): 1441 - 1450. [Abstract] [Full Text]
|
|
|
|
|
|
I. Yoshino, H. Yokoyama, T. Yano, T. Ueda, E. Takai, K. Mizutani, H. Asoh, and Y. Ichinose Skip Metastasis to the Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer Ann. Thorac. Surg., October 1, 1996; 62(4): 1021 - 1025. [Abstract] [Full Text]
|
|
|
|
|
|
J. R. Izbicki, B. Passlick, O. Karg, C. Bloechle, K. Pantel, W. T. Knoefel, and O. Thetter Impact of Radical Systematic Mediastinal Lymphadenectomy on Tumor Staging in Lung Cancer Ann. Thorac. Surg., January 1, 1995; 59(1): 209 - 214. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
